Compared across 2 stores. Prices are checked against each store and labelled with when.
It checks today's price at every store, compares the alternatives and answers in about a minute.
Zepbound is a once-weekly prescription injection of tirzepatide, a dual GLP-1 and GIP receptor agonist approved for weight management in adults with obesity or overweight plus a weight-related condition. It is the same molecule sold as Mounjaro for type 2 diabetes. In trials, tirzepatide produced larger average weight loss than semaglutide (Wegovy) at comparable durations, which is why many clinicians reach for it first. It is a refrigerated prescription product given by pen, so it suits people working with a prescriber rather than buying off the shelf.
In stock
In stock
Lowest price we've seen: $1,199.99 on Nov 9 at TelyRx. Tracked across 2 stores since Nov 9.
Users and clinicians widely report strong appetite suppression and steady weight loss, often more than with semaglutide. Most complaints center on gastrointestinal side effects in the first weeks and on refrigeration and supply logistics.
Zepbound is a tirzepatide injection supplied as pen-style prefilled syringes. Each dose is 12 mg/0.5 mL. Tirzepatide combines two hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).
The medicine is injected once weekly. It stimulates insulin production and reduces glucose release from the liver, which helps lower blood sugar. It may also aid in weight loss.
This is a prescription medication. It must be kept refrigerated.
